The jabs contain special types of RNA called small interfering RNA (siRNA) and RNA interference (RNAi). You don’t want either inside of your body. Trust me. https://t.co/lsw1tJVF6i
@Ron7350 See: https://t.co/lsw1tJVF6i And trust me, you don’t want either siRNA or RNAi inside of your body.
@0k8Ktj82UPGuY9m RNAi創薬やったことないからなぁ(触れたこともない)。 SARS-CoVの時は実験室レベルではS蛋白標的が一番効率良かったけど、DDSの問題があり治療薬として現実的でなかったようです。 今はある程度狙えるのではないでしょうか。 https://t.co/sguNOYjX1h
@
#immunology #Pathogenesis #Covid #SARSCoV2 #immunity #antibodies #Covid #CovidVaccine implications
#SARSCoV2 infects in presence of neutralizing #antibodies #Covidvaccines "SARS-CoV-2 is ... able to spread directly from cell to cell, avoiding the neutralizing antibodies present in the extracellular space, at a significantly higher rate than SARS-Cov"
#Covid #antibodies #Covidvaccine #SARSCoV2 "A recent study suggested that SARS-CoV-2 is also able to spread directly from cell to cell, avoiding the neutralizing antibodies present in the extracellular space, at a significantly higher rate than SARS-Cov"
Odd statement: "Unfortunately, due to relatively small cases associated with SARS-CoV ... not so much attention was paid to using RNAi for management of the disease" #Covid as opportunity for #RNAi #Biotech #Covidprofiteering 🤔 #siRNA https://t.co/0AIVBbV
RT @FrontBioeng: Check out this review article on "Prospects for RNAi Therapy of COVID-19" published by our Specialty Chief Editor of Bioma…
Check out this review article on "Prospects for RNAi Therapy of COVID-19" published by our Specialty Chief Editor of Biomaterials, Hasan Uludag. Read more here: https://t.co/qL9ipxxRBh #COVID19 #openaccess #antiviral #RNAi https://t.co/obDMNsd4A0
RT @pt117cool: $ARWR - Fm-Yahoo - postcall40 minutes ago https://t.co/WgcUhbBank Note- Interesting reading, when you have time
$ARWR - Fm-Yahoo - postcall40 minutes ago https://t.co/WgcUhbBank Note- Interesting reading, when you have time
RT @FrontBioeng: Check out a recent article from our #Biomaterials Specialty Chief Editor, Prof. Hasan Uludag and researchers from @UAlbert…
RT @FrontBioeng: Check out a recent article from our #Biomaterials Specialty Chief Editor, Prof. Hasan Uludag and researchers from @UAlbert…
Check out a recent article from our #Biomaterials Specialty Chief Editor, Prof. Hasan Uludag and researchers from @UAlberta @usask @ChapmanPharmacy on the development of front line therapies against #SARS_CoV_2 here: https://t.co/F6v1PWulgm #COVIDー19 #s
New Research: Prospects for RNAi Therapy of COVID-19: COVID-19 caused by the SARS-CoV-2 virus is a fast emerging disease with deadly consequences. The pulmonary system and lungs in particular are most prone to damage caused by… https://t.co/QLD0V55Plr #bio